245 related articles for article (PubMed ID: 18798231)
1. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
Addeo R; De Rosa C; Faiola V; Leo L; Cennamo G; Montella L; Guarrasi R; Vincenzi B; Caraglia M; Del Prete S
Cancer; 2008 Nov; 113(9):2524-31. PubMed ID: 18798231
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors.
Kouvaris JR; Miliadou A; Kouloulias VE; Kolokouris D; Balafouta MJ; Papacharalampous XN; Vlahos LJ
Onkologie; 2007 Jul; 30(7):361-6. PubMed ID: 17596744
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
[TBL] [Abstract][Full Text] [Related]
4. Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study.
Giorgio CG; Giuffrida D; Pappalardo A; Russo A; Santini D; Salice P; Blanco G; Castorina S; Failla G; Bordonaro R
Lung Cancer; 2005 Nov; 50(2):247-54. PubMed ID: 16039010
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
Tian J; Luo Y; Xiang J; Tang J
J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
[TBL] [Abstract][Full Text] [Related]
6. Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.
Siena S; Crinò L; Danova M; Del Prete S; Cascinu S; Salvagni S; Schiavetto I; Vitali M; Bajetta E
Ann Oncol; 2010 Mar; 21(3):655-661. PubMed ID: 19767314
[TBL] [Abstract][Full Text] [Related]
7. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.
Sperduto PW; Wang M; Robins HI; Schell MC; Werner-Wasik M; Komaki R; Souhami L; Buyyounouski MK; Khuntia D; Demas W; Shah SA; Nedzi LA; Perry G; Suh JH; Mehta MP
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1312-8. PubMed ID: 23391814
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial.
Verger E; Gil M; Yaya R; Viñolas N; Villà S; Pujol T; Quintó L; Graus F
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):185-91. PubMed ID: 15629610
[TBL] [Abstract][Full Text] [Related]
9. Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study.
Chua D; Krzakowski M; Chouaid C; Pallotta MG; Martinez JI; Gottfried M; Curran W; Throuvalas N
Clin Lung Cancer; 2010 May; 11(3):176-81. PubMed ID: 20439193
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
11. Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.
Cao KI; Lebas N; Gerber S; Levy C; Le Scodan R; Bourgier C; Pierga JY; Gobillion A; Savignoni A; Kirova YM
Ann Oncol; 2015 Jan; 26(1):89-94. PubMed ID: 25355723
[TBL] [Abstract][Full Text] [Related]
12. Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases.
Addeo R; Sperlongano P; Montella L; Vincenzi B; Carraturo M; Iodice P; Russo P; Parlato C; Salzano A; Cennamo G; Lombardi A; Sperlongano R; Prete SD; Caraglia M
Cancer Chemother Pharmacol; 2012 Oct; 70(4):603-9. PubMed ID: 22890892
[TBL] [Abstract][Full Text] [Related]
13. Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer.
Wang Q; Jiang Z; Qi X; Lu S; Wang S; Leng C; Lu F; Liu H; Liang S; Shi J
Clin Transl Oncol; 2014 Nov; 16(11):1000-5. PubMed ID: 24894840
[TBL] [Abstract][Full Text] [Related]
14. Whole brain reirradiation and concurrent temozolomide in patients with brain metastases.
Minniti G; Scaringi C; Lanzetta G; Bozzao A; Romano A; De Sanctis V; Valeriani M; Osti M; Enrici RM
J Neurooncol; 2014 Jun; 118(2):329-334. PubMed ID: 24718862
[TBL] [Abstract][Full Text] [Related]
15. Whole-brain irradiation with concomitant daily fixed-dose temozolomide for brain metastases treatment: a randomised phase II trial.
Gamboa-Vignolle C; Ferrari-Carballo T; Arrieta Ó; Mohar A
Radiother Oncol; 2012 Feb; 102(2):187-91. PubMed ID: 22257825
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study.
Hassler MR; Pfeifer W; Knocke-Abulesz TH; Geissler K; Altorjai G; Dieckmann K; Marosi C
Wien Klin Wochenschr; 2013 Aug; 125(15-16):481-6. PubMed ID: 23907204
[TBL] [Abstract][Full Text] [Related]
17. Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life.
Addeo R; Caraglia M; Faiola V; Capasso E; Vincenzi B; Montella L; Guarrasi R; Caserta L; Del Prete S
BMC Cancer; 2007 Jan; 7():18. PubMed ID: 17254350
[TBL] [Abstract][Full Text] [Related]
18. Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial.
Omuro AM; Raizer JJ; Demopoulos A; Malkin MG; Abrey LE
J Neurooncol; 2006 Jul; 78(3):277-80. PubMed ID: 16614943
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group.
Margolin K; Atkins B; Thompson A; Ernstoff S; Weber J; Flaherty L; Clark I; Weiss G; Sosman J; II Smith W; Dutcher P; Gollob J; Longmate J; Johnson D
J Cancer Res Clin Oncol; 2002 Apr; 128(4):214-8. PubMed ID: 11935312
[TBL] [Abstract][Full Text] [Related]
20. Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03).
Pesce GA; Klingbiel D; Ribi K; Zouhair A; von Moos R; Schlaeppi M; Caspar CB; Fischer N; Anchisi S; Peters S; Cathomas R; Bernhard J; Kotrubczik NM; D'Addario G; Pilop C; Weber DC; Bodis S; Pless M; Mayer M; Stupp R
Eur J Cancer; 2012 Feb; 48(3):377-84. PubMed ID: 22093943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]